PharmaPoint: Dry Eye Syndrome - India Drug Forecast and Market Analysis to 2022

1
PharmaPoint Dry Eye Syndrome - India Drug
Forecast and Market Analysis to 2022
One-Stop Shop for Business Information
2
Summary
Global Data has released its new Country report,
PharmaPoint Dry Eye Syndrome - India Drug
Forecast and Market Analysis to 2022. Dry eye
syndrome (DES), or keratoconjunctivitis sicca, is
a multifactorial disease of the eye caused by
dryness, decreased tear production, or increased
tear film evaporation. DES, which is often
referred to simply as dry eye, is the most
prevalent form of ocular discomfort and
irritation. The most common symptoms of DES are
ocular irritation and discomfort, foreign body
sensation, fatigue, and visual disturbances,
which interfere with daily activities. In the
elderly population, it is the most common reason
for seeking eye care, and this is expected to
increase exponentially with an aging demographic.
The DES market in India is projected to grow
during the forecast period. During the forecast
period, the primary market growth driver will be
increased awareness of DES and overall improved
access to medical care for Indias enormous
population.
3

• Scope
• Overview of the DES including epidemiology,
  etiology, symptoms, diagnosis, pathology and
  treatment guidelines as well as an overview on
  the competitive landscape.
• Detailed information on the key drugs in India
  including product description, safety and
  efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in India from
  2012-2022.
• Analysis of the impact of key events as well the
  drivers and restraints affecting India DES market.

4

• Reasons To Buy
• Understand and capitalize by identifying products
  that are most likely to ensure a robust return
• Stay ahead of the competition by understanding
  the changing competitive landscape for DES
• Effectively plan your MA and partnership
  strategies by identifying drugs with the most
  promising sales potential
• Make more informed business decisions from
  insightful and in-depth analysis of drug
  performance
• Obtain sales forecast for drugs from 2012-2022 in
  India.

5

• Reasons to buy
• Gain insights into creating and improving a
  merchant-funded rewards model
• Gain an understanding of industry best practice
• Learn about the most effective business models
• Get advice on improving merchant-funded rewards
  programs
• Understand the value chain of merchant-funded
  loyalty programs

6
Table of Contents

1. Table of Contents 4
2. Introduction 8
3. Disease Overview 10
4. Disease Management 17
5. Competitive Assessment 29
6. Opportunity and Unmet Need 39
7. Pipeline Assessment 47
8. Market Outlook 50
9. Appendix 53

7
Related Reports

• EGP-437 (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022
• MIM-D3 (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022
• CF101 (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022
• Diquas (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022
• Cyclokat (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022
• RX-10045 (Dry Eye Syndrome) - Forecast and Market
  Analysis to 2022

8
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and
  benchmarks.
• http//www.bharatbook.com/customResearch.asp

9
For More Information You Can Visit

• http//www.bharatbook.com/healthcare-market-resear
  ch-reports/pharmapoint-dry-eye-syndrome-india-drug
  -forecast-and-market-analysis-to-20221.html

Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 For Live
Chat - http//bit.ly/19m3TU4
Follow/Like Us on-